Agilent Technologies Partners with Proteome Systems for Glycomics Applications, Software Development
Collaboration to Hasten Drug & Diagnostic Marker Discovery
Proteome Systems Ltd. and Agilent Technologies Inc. announced the expansion of their cooperative marketing agreement to develop new workflow solutions for the discovery of diagnostic markers and drug targets by glycomics analysis.
Proteome Systems will use its expertise in biomarker discovery to provide Agilent with glycomics applications and software development for use with Agilent's mass spectrometer range of instruments. Agilent will provide its new, high-sensitivity HPLC/Chip-based 6240 Ion Trap LC/MS system for the mass spectrometric analysis of protein-associated glycans.
"Changes in the glycosylation patterns of proteins in cancers are well-known indicators for the progression of the disease," said Dr. Nicolle Packer, Proteome Systems' program leader in cancer proteomics. "Our lead prostate cancer program, in collaboration with U.S.-based Egenix Inc., will benefit enormously from the cooperative technology program with Agilent. We are confident that the glycomics community in general will benefit from the development of new instruments, software and tools. We have successfully worked in this area for many years and are well placed to provide complete analysis solutions to Agilent for this type of discovery application."
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you

Image Integrity Checker by Cytiva
Image integrity checker software - authenticate your images for publication
Safeguard and verify your image data with our free software

Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management

ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!

Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Last viewed contents
Zif268
Acute_abdomen
Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development
